Valuation : Brooks Laboratories Limited

Market Cap 1.99B 21.09M 18.13M 17.06M 15.57M 29.12M 29.21M 202M 78.17M 1.02B 79.19M 77.46M 3.25B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 2.01B 21.28M 18.3M 17.21M 15.71M 29.39M 29.48M 204M 78.89M 1.03B 79.92M 78.17M 3.28B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-18 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-06 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
28/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
26/12/24 Brooks Laboratories Limited Appoints Ms. Krutika Mohan Rane as Company Secretary & Compliance Officer, Effective 26 December 2024 CI
1 day-6.50%
1 week-4.77%
Current month-4.87%
1 month+5.68%
3 months-5.04%
6 months+8.28%
Current year-21.01%
1 week 61.52
Extreme 61.52
70.8
1 month 58.5
Extreme 58.5
71.4
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
163.9
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 22/01/2002
Chief Executive Officer - 31/05/2026
President 57 22/08/2023
Director TitleAgeSince
Director/Board Member 53 22/11/2022
Director/Board Member 62 09/09/2010
Director/Board Member - 22/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-6.50%-4.77%-57.15%-42.43% 21.09M
-0.48%-2.23%+19.29%+66.83% 48.08B
+0.60%-4.76%+39.20%+117.99% 39.95B
-0.79%-2.74%-10.20%+11.20% 11.92B
-0.99%-1.91%+13.46%+82.36% 12.2B
-1.50%-0.38%+24.76%+138.18% 9.22B
-0.39%-3.51%+21.87%+34.65% 7.41B
+0.25%-2.45%+36.48%-13.41% 7.37B
+0.92%+0.17%+20.60%+218.53% 7.32B
-0.32%-1.85%-46.31%+22.01% 5.17B
Average -0.93%-1.67%+6.20%+63.59% 14.87B
Weighted average by Cap. -0.21%-3.11%+20.89%+82.13%

Financials

2025 2026
Net sales 826M 8.73M 7.51M 7.06M 6.45M 12.05M 12.09M 83.72M 32.36M 423M 32.78M 32.07M 1.35B 857M 9.07M 7.8M 7.33M 6.69M 12.52M 12.56M 86.95M 33.61M 439M 34.05M 33.3M 1.4B
Net income -99.67M -1.05M -906K -852K -778K -1.46M -1.46M -10.11M -3.91M -51.04M -3.96M -3.87M -163M 246M 2.6M 2.24M 2.1M 1.92M 3.59M 3.6M 24.93M 9.64M 126M 9.76M 9.55M 401M
Net Debt 75.39M 797K 686K 645K 589K 1.1M 1.1M 7.65M 2.96M 38.61M 2.99M 2.93M 123M 18.44M 195K 168K 158K 144K 269K 270K 1.87M 723K 9.44M 732K 716K 30.08M
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
08/09/26 63.30 -6.50% 64,342
07/09/26 ₹67.70 +2.47% 25,779
04/09/26 ₹66.07 +2.99% 12,920
03/09/26 ₹64.15 -1.46% 24,891
02/09/26 ₹65.10 -2.06% 23,544
  1. Stock Market
  2. Stocks
  3. BROOKS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!